Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis

Hepatology

Volumn 49, Issue 6, 2009, Pages 1888-1895

  Caldwell, Stephen H ^a   de Freitas, Luiz Antonio R ^b   Park, Sang H ^a,c   Moreno, Maria Lucia V ^b   Redick, Jan A ^a   Davis, Christine A ^a   Sisson, Barbee J ^a   Patrie, James T ^a   Cotrim, Helma ^d   Argo, Curtis K ^a   Al Osaimi, Abdullah ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Hallym University   (South Korea)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CELL INCLUSION; CELL STRUCTURE; FEMALE; HEART MITOCHONDRION; HUMAN; HUMAN TISSUE; INTRAMITOCHONDRIAL CRYSTAL; LIPID COMPOSITION; LIVER BIOPSY; MICELLE; MICROENVIRONMENT; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; PHASE TRANSITION; PRIORITY JOURNAL; TEMPERATURE STRESS; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; AGED; CRYSTALLIZATION; FATTY LIVER; FEMALE; HUMANS; MIDDLE AGED; MITOCHONDRIA; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 68949086361     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22851     Document Type: Article

References (63)

1. Sternlieb I. Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology 1968;55:354-367.
2. Spycher MA, Ruttner JR. Kristalloide Einschlusse in menschlichen Lebermitochondrien. Virch Arch Abt B Zellpath 1968;1:211-221.
3. Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, et al. Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies. J Gastro and Hepatol 2003;18:1272-1282.
4. Chedid A, Mendenhall CL, Tosch T, Chen T, Rabin L, Garcia-Pont P, et al. Significance of megamitochondria in alcoholic liver disease. Gastroenterology 1986;90:1858-1864.
5. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, et al. Mitochondrial abnormalities in nonalcoholic steatohepatitis. J Hepatol 1999;31:430-434.
6. Sobaniac-Lotowska ME, Lebensztejn DM. Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: Usefulness of electron microscopy in the diagnosis of the disease. Am J Gastroenterol 2003;98:1664-1665
7. Haust MD. Crystalloid structures of hepatic mitochondria in children with heparin sulphate mucopolysaccharidosis (San filipo type). Exp Mol Pathol 1968;8:123-134.
8. Petersen P. Ultrastructure of periportal and centrilobular hepatocytes in human fatty liver of various aetiology. Acta Path Microbiol Scan (Sect A) 1977;85:421-427.
9. Sanyal AJ, Campbell-Sargent C, Mirshani F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120: 1183-1192.
10. Le TH, Caldwell SH, Redick JA, Sheppard BL, Davis CA, Arseneau K, et al. The lobular distribution of mitochondrial abnormalities in NASH. HEPATOLOGY 2004;39:1423-1429.
11. Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard Bl. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterology 2001;96:519-525.
12. Caldwell SH, Patrie JT, Brunt EM, Redick JA, Davis CA, Park SH, et al. Increased mitochondrial crystalline inclusions after 48 weeks of rosiglitazone in human nonalcoholic steatohepatitis (NASH). HEPATOLOGY 2007; 46:1101-1107.
13. Williams WP, Selstam E, Brain T. X-ray diffraction studies of the structural organisation of prolamellar bodies isolated from Zea mays. FEBS Lett 1998:422:252-254.
14. Wolf SG, Frenkiel D, Arad T, Finkel SE, Kolter R, Minsky A. DNA protection by stress-induced biocrystallization. Nature 1999:400:83-85.
15. Svoboda DJ, Manning RT. Chronic alcoholism with fatty metamorphosis of the liver. Mitochondrial alterations in hepatic cells. Am J Pathol 1964; 44:645-662.
16. Sternlieb I, Berger JE. Optical diffraction studies of crystalline structures in electron micrographs. J Cell Biol 1969;43:448-455.
17. Mannella CA. Structure and dynamics of the mitochondrial inner membrane cristae. Biochim Biophys Acta 2006;1763:542-548.
18. Amar-Yuli I, Wachtel E, Shalev DE, Moshe H, Aserin A, Garti N. Thermally induced fluid reversed hexagonal (HII) mesophase. J Phys Chem B 2007;111:13544-13553.
19. May ER, Kopelevich DI, Narang A. Coarse-grained molecular dynamics simulations of phase transitions in mixed lipid systems containing LPA, DOPA, and DOPE lipids. Biophys J 2008;94:878-90.
20. Tsvetkova NM, Horváth I, Török Z, Wolkers WF, Balogi Z, Shigapova N, et al. Small heat-shock proteins regulate membrane lipid polymorphism. Proc Natl Acad Sci U S A 2002:99:13504-13509.
21. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histologic lesions. Am J Gastroenterol 1999;94:2467-2474.
22. Kleiner DE, Brunt EM, Van Natta ML, Behling C, Contos MJ, Cummings OW, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histologic scoring system for NAFLD. HEPATOLOGY 2005;41:1313-1321.
23. Edgington ES. Randomization Tests. 3rd ed. New York: Marcel Dekker, 1995.
24. Morgan BJT. Elements of Simulation. London: Chapman & Hall, 1984.
25. Elston RC. On Fisher's method of combining p-values. Biom J 1991;88: 339-345.
26. Dianzani MU. The content of adenosine polyphosphates in fatty livers. Biochem J 1957;65:116-124.
27. Pessayre D, Fromenty B. NASH: A mitochondrial disease. J Hepatol 2005; 42:928-940.
28. Caldwell SH, Chang CY, Nakamoto RK, Krugner-Higby L. Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:595-617.
29. Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: A dysfunctional relationship. Gastroenterology 2002;122:2049-2063.
30. Peralta C, Rosello-Catafau J. The future of fatty livers. J Hepatol 2004;41: 149-151.
31. Kojima H, Sakurai S, Uemura M, Fukui H, Morimoto H, Tamagawa Y. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2007;31:61S-66S.
32. Cortez-Pinto H, Chatham J, Chako VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA 1999;282:1659-1664.
33. Pérez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martín A, Castellano G, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. HEPATOLOGY 2003;38:999-1007.
34. Raffaella C, Francesca B, Italia F, Marina P, Giovanna L, Sussana I. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity 2008;16:958-964.
35. Li ZZ, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomalmitochondrial axis in free fatty acid-induced hepatic lipotoxicity. HEPATOLOGY 2008;47:1495-1503.
36. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. HEPATOLOGY 2006;44: 27-33.
37. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997;91:627-637.
38. Ramalho RM, Cortez-Pinto H, Castro RE, Sola S, Costa A, Moura MC, et al. Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis. Euro J Gastro Hepatol 2006;18:21-29.
39. Krahenbuhl S. Alterations in mitochondrial function and morphology in chronic liver disease: Pathogenesis and potential for therapeutic intervention. Pharmac Ther 1993;60:1-38.
40. Williams WP, Selstam E, Brain T. X-ray diffraction studies of the structural organization of prolamellar bodies isolated from Zea Mays. FEBS Lett 1998;422:252-254.
41. Frazier BA, Pfeifer JD, Russell DG, Falk P, Olsén AN, Hammar M, et al. Paracrystalline inclusions of a novel ferritin containing nonheme iron, produced by the human gastric pathogen Helicobacter pylori: evidence for a third class of ferritins. J Bacteriol 1993:175:966-972.
42. Deng Y, Kohlwein SD, Mannella CA. Fasting induces cyanide-resistant respiration and oxidative stress in the amoeba Chaos carolinensis: implications for the cubic structural transition in mitochondrial membranes. Protoplasma 2002:219:160-167.
43. Almsherqi ZA, Kohlwein SD, Deng Y. Cubic membranes: A legend beyond the Flatland of cell membrane organization. J Cell Biol 2006;173:839-844.
44. Cambrea LR, Hovis JS. Formation of three-dimensional structures in supported lipid bilayers. Biophys J 2007;92:3587-3594.
45. Foht PJ, Tran QM, Lewis RNAH, McElhaney RN. Quantitation of the phase preference of the major lipids of the Acholeplasma laidlawii B membrane. Biochemistry 1995;34:13811-13817.
46. Li QT, Yeo MH, Tan BK. Lipid peroxidation in small and large phospholipid unilamellar vesicles induced by water-soluble free radical sources. Biochem Biophys Res Commun 2000:273:72-76.
47. Krishnaswamy R, Pabst G, Rappolt M, Raghunathan VA, Sood AK. Structure of DNA-CTAB-hexanol complexes. Phys Rev E Stat Nonlin Soft Matter Phys 2006;73:031904.
48. Shah J, Atienza JM, Rawlings AV, Shipley GG. Physical properties of ceramides: Effect of fatty acid hydroxylation. J Lipid Res 1995;36:1945-1955.
49. de Kruijff B, Cullis PR. Cytochrome c specifically induces non-bilayer structures in cardiolipin-containing model membranes. Biochim Biophys Acta 1980;602:477-490.
50. Cullis PR, de Kruijff B, Hope MJ, Nayar R, Rietveld A, Verkleij AJ. Structural properties of phospholipids in the rat liver inner mitochondrial membrane. Biochim Biophys Acta 1980:600:625-635.
51. Bouwstra JA, Gooris GS, Dubbelaar FER, Ponec M. Phase behavior of lipid mixtures based on human ceramides: Coexistence of crystalline and liquid phases. J Lipid Res 2001;42:1759-1770.
52. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. HEPATOLOGY 2007; 46:1081-1090.
53. McClain CJ, Barve S, Deaciuc I. Good fat/bad fat. HEPATOLOGY 2007;45: 1343-1346.
54. Horimoto M, Fulop P, Derdak Z, Wands JR, Baffy G. Uncoupling protein 2 deficiency promotes oxidant stress and delays liver regeneration in mice. HEPATOLOGY 2004;39:386-392.
55. Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, Romano AD, et al. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 2008;57:957-965.
56. Fulop P, Derdak Z, Sheets A, Sabo E, Berthiaume EP, Resnick MB, et al. Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression. HEPATOLOGY 2006;44:592-601.
57. Baffy G. Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 2005;10:2082-2096.
58. Frazier AE, Kiu C, Stojanovski D, Hoogenraad NJ, Ryan MT. Mitochondrial morphology and distribution in mammalian cells. Biol Chem 2006; 387:1551-1558.
59. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Manella CA, et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2002;2:55-67.
60. Arnoult D, Grodet A, Lee YJ, Estaquier J, Blackstone C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem 2005;280:35742-35750.
61. Chiappini F, Barrier A, Saffroy R, Domart M-C, Dagues N, Azoulay D, et al. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab Invest 2006;86:154-165.
62. Nomoto K, Tsuneyama K, Takahashi H, Murai Y, Takano Y. Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease. Appl Immunohistochem Mol Morphol 2008;16:71-75.
63. Cullis PR, de Kruijff B, Hope MJ, Nayar R, Rietveld A, Verkleij AJ. Structural properties of phospholipids in the rat liver inner mitochondrial membrane. Biochim Biophys Acta 1980;600:625-635.